ストックスクリーナーアプリを入手
2.11
1.44%
0.03
アフターアワーズ：
2.12
0.01
+0.47%
前日終値:
$2.08
開ける：
$2.08
24時間の取引高:
904.50K
Relative Volume:
1.10
時価総額：
$149.86M
収益：
-
当期純損益:
$-117.50M
株価収益率:
-0.8792
EPS:
-2.4
ネットキャッシュフロー:
$-114.31M
1週間 パフォーマンス:
-12.45%
1か月 パフォーマンス:
+1.93%
6か月 パフォーマンス:
-0.47%
1年 パフォーマンス:
-31.49%
1日の値動き範囲:
$2.07
$2.1795
1週間の範囲:
$2.035
$2.4399
52週間の値動き範囲:
$1.31
$3.8099
Nkarta Inc Stock (NKTX) Company Profile
名前
Nkarta Inc
セクター
電話
(925) 407-1049
住所
1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO
NKTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NKTX
Nkarta Inc
|
2.11 | 147.73M | 0 | -117.50M | -114.31M | -2.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 398.11M | -1.03B | -868.57M | -5.7032 |
Nkarta Inc Stock (NKTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-15 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2024-10-09 | 開始されました | Rodman & Renshaw | Buy |
| 2024-08-14 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2024-03-22 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2022-12-22 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-10-10 | 開始されました | Canaccord Genuity | Buy |
| 2022-07-28 | 開始されました | Needham | Buy |
| 2022-07-18 | 開始されました | SVB Leerink | Outperform |
| 2022-03-11 | 開始されました | Raymond James | Outperform |
| 2022-03-08 | 開始されました | H.C. Wainwright | Buy |
| 2022-01-06 | 開始されました | William Blair | Outperform |
| 2021-11-18 | 開始されました | SMBC Nikko | Outperform |
| 2021-07-16 | 開始されました | Oppenheimer | Outperform |
| 2020-08-04 | 開始されました | Cowen | Outperform |
| 2020-08-04 | 開始されました | Evercore ISI | Outperform |
| 2020-08-04 | 開始されました | Mizuho | Buy |
| 2020-08-04 | 開始されました | Stifel | Buy |
すべてを表示
Nkarta Inc (NKTX) 最新ニュース
What drives Nkarta Inc stock priceRisk Mitigation Techniques & Low Entry Cost Investments - earlytimes.in
Can machine learning forecast Nkarta Inc. recoveryJuly 2025 Weekly Recap & High Accuracy Investment Signals - newser.com
Nkarta Inc. stock chart pattern explainedProduct Launch & Short-Term Trading Opportunity Alerts - newser.com
Risk adjusted return profile for Nkarta Inc. analyzed2025 Retail Activity & Verified Entry Point Signals - newser.com
Nkarta Inc. stock prediction for this weekPortfolio Return Report & Low Volatility Stock Suggestions - newser.com
Using Python tools to backtest Nkarta Inc. strategiesJuly 2025 Earnings & Daily Risk Controlled Trade Plans - newser.com
Will Nkarta Inc. stock gain from government policies2025 Market Sentiment & Free High Accuracy Swing Entry Alerts - newser.com
Is Nkarta Inc. stock supported by strong fundamentalsSwing Trade & Weekly Top Performers Watchlists - newser.com
Will Nkarta Inc. stock deliver strong dividend growth2025 Top Gainers & Low Risk Entry Point Guides - newser.com
Will Nkarta Inc. stock sustain high P E ratiosPortfolio Value Summary & Accurate Intraday Trade Tips - newser.com
Will Nkarta Inc. stock continue upward momentumMarket Movement Recap & AI Powered Market Entry Strategies - newser.com
Nkarta to Participate in November Investor Conferences - Bluefield Daily Telegraph
Nkarta (NKTX) to Release Earnings on Thursday - MarketBeat
Real time alert setup for Nkarta Inc. performanceWall Street Watch & Low Drawdown Investment Ideas - newser.com
What momentum indicators show for Nkarta Inc. stockTrade Signal Summary & Expert Approved Momentum Ideas - newser.com
Nkarta’s NKX019 Study: A Promising Step in Autoimmune Disease Treatment - TipRanks
How Nkarta Inc. stock responds to policy changesJuly 2025 Review & Free High Return Stock Watch Alerts - Fundação Cultural do Pará
Is Nkarta Inc. stock a defensive play in 20252025 Retail Activity & Consistent Income Trade Recommendations - Fundação Cultural do Pará
Nkarta Inc Stock Analysis and ForecastStock Split Announcements & Free Unmatched Market Gains - earlytimes.in
Nkarta, Inc. Advances CAR NK Cell Therapy Study for Immune-Mediated Diseases - TipRanks
Why retail investors favor Nkarta Inc. stockJuly 2025 Trade Ideas & Reliable Breakout Stock Forecasts - Fundação Cultural do Pará
Nkarta Inc (NKTX) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):